Somanetics Corp (NASDAQ:SMTS)

CAPS Rating: 4 out of 5

Develops, manufactures and markets the INVOS Cerebral Oximeter, the only non-invasive patient monitoring system commercially available in the United States that continuously measures changes in the blood oxygen level in the adult brain.

Recs

1
Player Avatar tomk0508 (82.62) Submitted: 5/11/2008 6:51:32 PM : Outperform Start Price: $16.73 SMTS Score: +50.93

Great business model solid margins nothing but growth ahead.

Featured Broker Partners


Advertisement